PHARVARIS NV (PHVS) Fundamental Analysis & Valuation
NASDAQ:PHVS • NL00150005Y4
Current stock price
28.685 USD
+0.8 (+2.89%)
Last:
This PHVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. PHVS Profitability Analysis
1.1 Basic Checks
- PHVS had negative earnings in the past year.
- In the past year PHVS has reported a negative cash flow from operations.
- PHVS had negative earnings in each of the past 5 years.
- PHVS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of PHVS (-58.28%) is worse than 69.11% of its industry peers.
- PHVS has a Return On Equity (-64.77%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.28% | ||
| ROE | -64.77% | ||
| ROIC | N/A |
ROA(3y)-43.22%
ROA(5y)-39.06%
ROE(3y)-47.05%
ROE(5y)-42.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PHVS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. PHVS Health Analysis
2.1 Basic Checks
- PHVS has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, PHVS has more shares outstanding
- Compared to 1 year ago, PHVS has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 27.79 indicates that PHVS is not in any danger for bankruptcy at the moment.
- The Altman-Z score of PHVS (27.79) is better than 91.10% of its industry peers.
- PHVS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- PHVS has a Debt to Equity ratio (0.00) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 27.79 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- PHVS has a Current Ratio of 10.11. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 10.11, PHVS is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
- PHVS has a Quick Ratio of 10.11. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of PHVS (10.11) is better than 80.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.11 | ||
| Quick Ratio | 10.11 |
3. PHVS Growth Analysis
3.1 Past
- PHVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.85%.
EPS 1Y (TTM)-20.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, PHVS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.95% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.39%
EPS Next 2Y6.65%
EPS Next 3Y16.21%
EPS Next 5Y27.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. PHVS Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for PHVS. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHVS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- PHVS's earnings are expected to grow with 16.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.65%
EPS Next 3Y16.21%
5. PHVS Dividend Analysis
5.1 Amount
- No dividends for PHVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PHVS Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:PHVS (4/14/2026, 2:26:28 PM)
28.685
+0.8 (+2.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-02 2026-04-02/bmo
Earnings (Next)05-11 2026-05-11/amc
Inst Owners58.88%
Inst Owner Change0%
Ins Owners5.32%
Ins Owner Change-0.2%
Market Cap1.88B
Revenue(TTM)N/A
Net Income(TTM)-175.70M
Analysts85.26
Price Target47.08 (64.13%)
Short Float %1.82%
Short Ratio4.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.7%
Min EPS beat(2)-13.69%
Max EPS beat(2)12.28%
EPS beat(4)1
Avg EPS beat(4)-4.04%
Min EPS beat(4)-13.69%
Max EPS beat(4)12.28%
EPS beat(8)4
Avg EPS beat(8)-1.86%
EPS beat(12)7
Avg EPS beat(12)-2.72%
EPS beat(16)10
Avg EPS beat(16)-0.6%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.52%
PT rev (3m)0.52%
EPS NQ rev (1m)-9.89%
EPS NQ rev (3m)-9.89%
EPS NY rev (1m)-7.13%
EPS NY rev (3m)-7.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.92 | ||
| P/tB | 5.92 | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.5
EYN/A
EPS(NY)-3.52
Fwd EYN/A
FCF(TTM)-2.45
FCFYN/A
OCF(TTM)-2.45
OCFYN/A
SpS0
BVpS4.85
TBVpS4.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.28% | ||
| ROE | -64.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-43.22%
ROA(5y)-39.06%
ROE(3y)-47.05%
ROE(5y)-42.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.34% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 10.11 | ||
| Quick Ratio | 10.11 | ||
| Altman-Z | 27.79 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)91.29%
Cap/Depr(5y)103.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
EPS Next Y-0.39%
EPS Next 2Y6.65%
EPS Next 3Y16.21%
EPS Next 5Y27.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.37%
EBIT Next 3Y34.47%
EBIT Next 5Y31.88%
FCF growth 1Y-13.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.1%
OCF growth 3YN/A
OCF growth 5YN/A
PHARVARIS NV / PHVS Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for PHARVARIS NV?
ChartMill assigns a fundamental rating of 2 / 10 to PHVS.
What is the valuation status for PHVS stock?
ChartMill assigns a valuation rating of 0 / 10 to PHARVARIS NV (PHVS). This can be considered as Overvalued.
What is the profitability of PHVS stock?
PHARVARIS NV (PHVS) has a profitability rating of 0 / 10.
How financially healthy is PHARVARIS NV?
The financial health rating of PHARVARIS NV (PHVS) is 6 / 10.